Amyloid-β-induced Alteration of Fast and Localized Calcium Elevations in Cultured Astrocytes
Kaito NakataiD, Joe SakamotoiD, Kohei OtomoiD, Masanao SatoiD, Hirokazu IshiiiD, Motosuke TsutsumiiD, Ryosuke EnokiiD, Tomomi NemotoiD
Abstract
Alzheimers disease (AD) is a progressive neurodegenerative disorder that causes cognitive decline. Uncovering the mechanisms of neurodegeneration in the early stages is essential to establish a treatment for AD. Recent research has proposed the hypothesis that amyloid-{beta} (A{beta}) oligomers elicit an excessive glutamate release from astrocytes toward synapses through intracellular free Ca2+ ([Ca2+]i) elevations in astrocytes, finally resulting in neuronal dendritic spine loss. Under physiological conditions, astrocytic [Ca2+]i elevations range spatially from microdomains to network-wide propagation and temporally from milliseconds to tens of seconds. Astrocytic localized and fast [Ca2+]i elevations might correlate with glutamate release; however, the A{beta}-induced alteration of localized, fast astrocytic [Ca2+]i elevations remains unexplored. In this study, we quantitatively investigated the A{beta} dimers-induced changes in the spatial and temporal patterns of [Ca2+]i in a primary culture of astrocytes by two-photon excitation spinning-disk confocal microscopy. The frequency of fast [Ca2+]i elevations occurring locally in astrocytes ([≤]0.5 s, [≤]35 {micro}m2) and [Ca2+]i event occupancy relative to cell area significantly increased after exposure to A{beta} dimers. The effect of A{beta} dimers appeared dose-dependently above 500 nM, and these A{beta} dimers-induced [Ca2+]i elevations were primarily mediated by a metabotropic purinergic receptor (P2Y1 receptor) and Ca2+ release from the endoplasmic reticulum. Our findings suggest that the A{beta} dimers-induced alterations and hyperactivation of astrocytic [Ca2+]i is a candidate cellular mechanism in the early stages of AD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- FWCI
- 2.55
- Field percentile
- top 11%
- Assay
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Amyloid pathology disrupts gliotransmitter release in astrocytes
Anup G. Pillai, Suhita Nadkarni·PLoS Computational BiologyPeer-reviewed·Aug 1, 2022
- Simulation of Ca2+ oscillations in astrocytes mediated by amyloid beta in Alzheimer's disease
- An increased excitation and inhibition onto CA1 pyramidal cells sets the path to Alzheimer's disease
Patrick H. Wehrle, Travis J. Rathwell, … Annalisa Scimemi·bioRxiv·May 27, 2025
- Astrocytic C-X-C motif chemokine ligand-1 mediates β-amyloid-induced tau mislocalization and synaptotoxicity
Beatriz Gomez Perez‐Nievas, Louisa Johnson, … Wendy J. Noble·Journal of NeuroinflammationPeer-reviewed·Dec 1, 2021
- Astrocytic uptake of posttranslationally modified amyloid-β leads to endolysosomal system disruption and induction of pro-inflammatory signaling
Sarah Wirth, Annika Schlößer, … Katarzyna M. Grochowska·GliaPeer-reviewed·Apr 17, 2024
- Impaired neuromodulator crosstalk delays vigilance-dependent astroglia Ca2+ activation in mouse models of Alzheimer's disease
Eunice Y. Lim, Angelica Salinas, … Martin Paukert·bioRxiv·Jun 27, 2022